{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:12Z","timestamp":1793731032640,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017981","name":"Sysmex Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06664-9","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:42:32Z","timestamp":1751384552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry"],"prefix":"10.1038","volume":"15","author":[{"given":"Kohjin","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tsukune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaaki","family":"Inano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Tomoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoiku","family":"Takaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6664_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley, J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290\u2013293 (1973).","journal-title":"Nature"},{"key":"6664_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01630378","volume":"8","author":"PC Nowell","year":"1962","unstructured":"Nowell, P. C. The minute chromosome (Phl) in chronic granulocytic leukemia. Blut 8, 65\u201366 (1962).","journal-title":"Blut"},{"key":"6664_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5045\/br.2022.2021173","volume":"57","author":"MA Samad","year":"2022","unstructured":"Samad, M. A., Mahboob, E. & Mansoor, H. Chronic myeloid leukemia: A type of MPN. Blood Res. 57, 95\u2013100 (2022).","journal-title":"Blood Res."},{"key":"6664_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-023-00823-9","volume":"13","author":"J Senapati","year":"2023","unstructured":"Senapati, J. et al. Management of chronic myeloid leukemia in 2023\u2014Common ground and common sense. Blood Cancer J. 13, 58 (2023).","journal-title":"Blood Cancer J."},{"key":"6664_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker, B. J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2, 561\u2013566 (1996).","journal-title":"Nat. Med."},{"key":"6664_CR6","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","volume":"34","author":"H Bower","year":"2016","unstructured":"Bower, H. et al. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J. Clin. Oncol. 34, 2851\u20132857 (2016).","journal-title":"J. Clin. Oncol."},{"key":"6664_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.beha.2016.10.005","volume":"29","author":"R Hehlmann","year":"2016","unstructured":"Hehlmann, R., Saussele, S., Voskanyan, A. & Silver, R. T. Management of CML-blast crisis. Best Pract. Res. Clin. Haematol. 29, 295\u2013307 (2016).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"6664_CR8","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood.2020004834","volume":"135","author":"TK Ko","year":"2020","unstructured":"Ko, T. K. et al. An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia. Blood 135, 2337\u20132353 (2020).","journal-title":"Blood"},{"key":"6664_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cas.14698","volume":"112","author":"D Koyama","year":"2021","unstructured":"Koyama, D., Kikuchi, J., Kuroda, Y., Ohta, M. & Furukawa, Y. AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells. Cancer Sci. 112, 194\u2013204 (2021).","journal-title":"Cancer Sci."},{"key":"6664_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41467-021-27928-8","volume":"13","author":"Y Tanaka","year":"2022","unstructured":"Tanaka, Y. et al. Eliminating chronic myeloid leukemia stem cells by IRAK1\/4 inhibitors. Nat. Commun. 13, 271 (2022).","journal-title":"Nat. Commun."},{"key":"6664_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.769730","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Zou, J., Cheng, F. & Li, W. Treatment-free remission in chronic myeloid leukemia and new approaches by targeting leukemia stem cells. Front. Oncol. 11, 769730 (2021).","journal-title":"Front. Oncol."},{"key":"6664_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11899-016-0309-2","volume":"11","author":"L Caldemeyer","year":"2016","unstructured":"Caldemeyer, L., Dugan, M., Edwards, J. & Akard, L. Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia. Curr. Hematol. Malig. Rep. 11, 71\u201379 (2016).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"6664_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","volume":"63","author":"JE Sokal","year":"1984","unstructured":"Sokal, J. E. et al. Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia. Blood 63, 789\u2013799 (1984).","journal-title":"Blood"},{"key":"6664_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/leu.2015.261","volume":"30","author":"M Pfirrmann","year":"2016","unstructured":"Pfirrmann, M. et al. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. Leukemia 30, 48\u201356 (2016).","journal-title":"Leukemia"},{"key":"6664_CR15","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1182\/blood.2020005514","volume":"137","author":"N Shanmuganathan","year":"2021","unstructured":"Shanmuganathan, N. et al. Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia. Blood 137, 1196\u20131207 (2021).","journal-title":"Blood"},{"key":"6664_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/cncr.31187","volume":"124","author":"K Sasaki","year":"2018","unstructured":"Sasaki, K. et al. Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase. Cancer 124, 1160\u20131168 (2018).","journal-title":"Cancer"},{"key":"6664_CR17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.aan0096","volume":"360","author":"S Ota","year":"2018","unstructured":"Ota, S. et al. Ghost cytometry. Science 360, 1246\u20131251 (2018).","journal-title":"Science"},{"key":"6664_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jmicro\/dfaa005","volume":"69","author":"S Ota","year":"2020","unstructured":"Ota, S., Sato, I. & Horisaki, R. Implementing machine learning methods for imaging flow cytometry. Microscopy (Oxford) 69, 61\u201368 (2020).","journal-title":"Microscopy (Oxford)"},{"key":"6664_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cyto.a.23989","volume":"97","author":"H Adachi","year":"2020","unstructured":"Adachi, H. et al. Use of ghost cytometry to differentiate cells with similar gross morphologic characteristics. Cytom. A 97, 415\u2013422 (2020).","journal-title":"Cytom. A"},{"key":"6664_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67660","volume":"10","author":"M Ugawa","year":"2021","unstructured":"Ugawa, M. et al. In silico-labeled ghost cytometry. Elife 10, e67660 (2021).","journal-title":"Elife"},{"key":"6664_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cyto.a.24821","volume":"105","author":"Y Kawamura","year":"2024","unstructured":"Kawamura, Y. et al. Label-free cell detection of acute leukemia using ghost cytometry. Cytom. A 105, 196\u2013202 (2024).","journal-title":"Cytom. A"},{"key":"6664_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/cas.16424","volume":"116","author":"K Suzuki","year":"2025","unstructured":"Suzuki, K. et al. BCR::ABL1-induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia. Cancer Sci. 116, 673\u2013689 (2025).","journal-title":"Cancer Sci."},{"key":"6664_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ijlh.12575","volume":"39","author":"JR Furundarena","year":"2017","unstructured":"Furundarena, J. R. et al. Comparison of abnormal cell flagging of the hematology analyzers Sysmex XN and Sysmex XE-5000 in oncohematologic patients. Int. J. Lab. Hematol. 39, 58\u201367 (2017).","journal-title":"Int. J. Lab. Hematol."},{"key":"6664_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cca.2018.08.038","volume":"489","author":"A Ogasawara","year":"2019","unstructured":"Ogasawara, A. et al. A simple screening method for the diagnosis of chronic myeloid leukemia using the parameters of a complete blood count and differentials. Clin. Chim. Acta 489, 249\u2013253 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"6664_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12185-015-1826-9","volume":"102","author":"H Nakamae","year":"2015","unstructured":"Nakamae, H. et al. A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: Correlation of quantitation with major BCR-ABL mRNA kits. Int. J. Hematol. 102, 304\u2013311 (2015).","journal-title":"Int. J. Hematol."},{"key":"6664_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.leukres.2007.08.017","volume":"32","author":"T Burmeister","year":"2008","unstructured":"Burmeister, T. & Reinhardt, R. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts. Leuk. Res. 32, 579\u2013585 (2008).","journal-title":"Leuk. Res."},{"key":"6664_CR27","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMoa030513","volume":"349","author":"TP Hughes","year":"2003","unstructured":"Hughes, T. P. et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N. Engl. J. Med. 349, 1423\u20131432 (2003).","journal-title":"N. Engl. J. Med."},{"key":"6664_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2141.2011.08603.x","volume":"153","author":"L Foroni","year":"2011","unstructured":"Foroni, L. et al. Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. Br. J. Haematol. 153, 179\u2013190 (2011).","journal-title":"Br. J. Haematol."},{"key":"6664_CR29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/ajcp\/107.6.661","volume":"107","author":"O Kabutomori","year":"1997","unstructured":"Kabutomori, O., Iwatani, Y., Koh, T. & Yanagihara, T. CD16 antigen density on neutrophils in chronic myeloproliferative disorders. Am. J. Clin. Pathol. 107, 661\u2013664 (1997).","journal-title":"Am. J. Clin. Pathol."},{"key":"6664_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie, D., Helgason, G. V. & Copland, M. The leukaemia stem cell: Similarities, differences and clinical prospects in CML and AML. Nat. Rev. Cancer 20, 158\u2013173 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"6664_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley, G. Q., Van Etten, R. A. & Baltimore, D. Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 247, 824\u2013830 (1990).","journal-title":"Science"},{"key":"6664_CR32","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","volume":"119","author":"A Hamilton","year":"2012","unstructured":"Hamilton, A. et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood 119, 1501\u20131510 (2012).","journal-title":"Blood"},{"key":"6664_CR33","first-page":"65","volume":"1","author":"S Koschmieder","year":"2011","unstructured":"Koschmieder, S. & Schemionek, M. Mouse models as tools to understand and study BCR-ABL1 diseases. Am. J. Blood Res. 1, 65\u201375 (2011).","journal-title":"Am. J. Blood Res."},{"key":"6664_CR34","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1182\/blood.2023021119","volume":"142","author":"IS Pagani","year":"2023","unstructured":"Pagani, I. S. et al. Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy. Blood 142, 2192\u20132197 (2023).","journal-title":"Blood"},{"key":"6664_CR35","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1182\/blood.V92.12.4758","volume":"92","author":"N Takahashi","year":"1998","unstructured":"Takahashi, N., Miura, I., Saitoh, K. & Miura, A. B. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 92, 4758\u20134763 (1998).","journal-title":"Blood"},{"key":"6664_CR36","first-page":"1940","volume":"8","author":"E Torlakovic","year":"1994","unstructured":"Torlakovic, E., Litz, C. E., McClure, J. S. & Brunning, R. D. Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping\/FISH. Leukemia 8, 1940\u20131943 (1994).","journal-title":"Leukemia"},{"key":"6664_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41746-018-0029-1","volume":"1","author":"A Rajkomar","year":"2018","unstructured":"Rajkomar, A. et al. Scalable and accurate deep learning with electronic health records. NPJ Digit. Med. 1, 18 (2018).","journal-title":"NPJ Digit. Med."},{"key":"6664_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood.V82.2.456.456","volume":"82","author":"N Komatsu","year":"1993","unstructured":"Komatsu, N. et al. Establishment and characterization of an erythropoietin-dependent subline, UT-7\/Epo, derived from human leukemia cell line, UT-7. Blood 82, 456\u2013464 (1993).","journal-title":"Blood"},{"key":"6664_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06664-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06664-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06664-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:42:32Z","timestamp":1751384552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06664-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06664-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by Sysmex to T.T. as a collaborative research project. K.S. and T.T. have filed patent applications related to the label-free CML cell detection method. K.S., S.T., Kohei Y., Y.K., T.K., T.S., K.F., and Kazuhiro Y. are employees of Sysmex. Other authors declare no competing financial interests regarding this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21046"}}